Global Rank
#47008
Country Rank
#120
Market Cap
1.34 M
Price
0
Change (%)
5.56%
Volume
2.65 M
BioSenic S.A.'s latest marketcap:
1.34 M
As of 06/07/2025, BioSenic S.A.'s market capitalization has reached $1.34 M. According to our data, BioSenic S.A. is the 47008th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.34 M |
| Revenue (ttm) | 3.27 M |
| Net Income (ttm) | -8,476,764 |
| Shares Out | 652.86 M |
| EPS (ttm) | -0.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/05/2025 |
Market Cap Chart
Data Updated: 06/07/2025
BioSenic S.A.'s yearly market capitalization.
BioSenic S.A. has seen its market value drop from €3 M to €1.18 M since 2022, representing a total decrease of 60.80% and an annual compound decline rate (CAGR) of 31.89%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | €1.18 M | -37.45% |
| 12/31/2024 | €1.88 M | -80.19% |
| 12/29/2023 | €9.48 M | 216.37% |
| 12/30/2022 | €3 M |
Company Profile
About BioSenic S.A.
BioSenic S.A. is a pioneering biotech company dedicated to developing innovative clinical assets. The company leverages advanced technologies to address critical medical needs.
Key Technologies
- Allogeneic Cell and Gene Therapy Platform: Utilizes differentiated bone marrow-sourced mesenchymal stromal cells, storable at hospitals for immediate use.
- Arsenic TriOxide Platform: Focused on immuno-oncology applications, targeting conditions such as graft-versus-host disease (GvHD), systemic lupus erythematosus, and systemic sclerosis.
Investigational Products
- ALLOB: Currently in Phase IIb clinical trials for treating difficult tibial fractures.
- ArsciCor: Preparing for Phase III trials in GvHD with an oral treatment formulation.
Headquarters: Mont-Saint-Guibert, Belgium.
Frequently Asked Questions
-
What is BioSenic S.A.'s (EBR-BIOS) current market cap?As of 06/07/2025, BioSenic S.A. (including the parent company, if applicable) has an estimated market capitalization of $1.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does BioSenic S.A. (EBR-BIOS) rank globally by market cap?BioSenic S.A. global market capitalization ranking is approximately 47008 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.